This activity was planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of University of Minnesota and the American Association for Cancer Research. The University of Minnesota is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education activities for physicians.
CREDIT DESIGNATION STATEMENT
University of Minnesota designated this educational activity for a maximum of 28.5 Category 1 credits toward the AMA Physician’s Recognition Award. Each physician should claim only those credits that he/she actually spent in the activity.
STATEMENT OF EDUCATIONAL NEED, TARGET AUDIENCE, AND LEARNING OBJECTIVES
The future of cancer prevention relies not only on traditional approaches to prevention and early detection, but also increasingly on new approaches that will provide molecular profiles to allow early detection; develop risk models for identifying high risk individuals and populations; tailor prevention strategies based on genetic status; develop preclinical models such as gene targeting/knockout mice to test chemopreventive agents; help in identifying promising new targets for agent development; and improve surrogate endpoints. This fourth annual multidisciplinary conference linked the biology of the cancer process with its prevention and reversal in pre-invasive stages. It fostered translational research and strengthened the vitally important partnership between basic, clinical, and behavioral cancer prevention researchers and ensuing energies brought new approaches to the clinic and to the population more rapidly, and offered new agents that can effectively prevent or delay the onset or progression of a variety of cancers.
This international conference was presented for basic, translational, clinical, epidemiological and behavioral scientists and physician-scientists involved in cancer prevention research and all subdisciplines of biomedical science related to cancer prevention research.
Following this learning activity, participants should be able to:
- Describe the link between the biology of the cancer process with its prevention and reversal in pre-invasive stages.
- Apply cancer risk models to identify patients who are candidates for cancer chemoprevention drug treatment or for lifestyle change to reduce the chance of developing breast, prostate, or colon cancer,
- Critically assess results of clinical trials of drugs for cancer prevention.
- Understand opportunities and controversies surrounding thoracic CT scanning for early detection of lung cancers.
- Consider the use of anti-viral vaccines for the prophylaxis against viral infection and prevention of virus-associated human cancers.
- Better communicate with patients concerning cancer risk, cancer screening, and cancer prevention.
- Manage patients who are survivors of cancer and its treatment and are at risk for second cancers.
- Appropriately prescribe medications for tobacco addiction/dependence.
It is the policy of University of Minnesota that the information presented at University of Minnesota-sponsored CME activities will be unbiased and based on scientific evidence. To help participants make judgments about the presence of bias, University of Minnesota and the American Association for Cancer Research provided information that Program Committee members and speakers disclosed about financial relationships they had with commercial entities that produce or market products or services related to the content of this CME activity.
CLAIMING CME CREDIT
Individuals wishing to receive Category 1 credits for their attendance at this conference should obtain a Documentation of Attendance and Request for Credit form from the AACR Office of CME at (215) 440-9300 or firstname.lastname@example.org.
ACKNOWLEDGMENT OF SUPPORT
This educational activity was supported by an educational grant from AFLAC, Incorporated; AstraZeneca; Avon Foundation; Comprehensive Minority Biomedical Branch of the National Cancer Institute; Genentech, Incorporated; Qiagen, Incorporated; Mercantile Investment and Wealth Management; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; and the AACR-Women in Cancer Research.
QUESTIONS ABOUT CME?
Please contact the AACR Office of CME at (215) 440-9300 or email@example.com